Skip to content

13F-HR filed by Commodore Capital LP

Commodore Capital LP filed this 13F-HR for the quarter ended 2024-03-31, filed 2024-05-15, with 39 holding rows worth $1,495,487,511.

Accession
0001831942-24-000006
Filed
2024-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2024

A holdings report, 39 entries on the cover page, a total value of $1,495,487,511 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,495,487,511 with VALUE read as dollars as filed, 13F file number 028-20976. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
MERUS N VN5749R100COM4,360,000$196,330,800dollars as filed
VERA THERAPEUTICS INC92337R101COMMON STOCK3,165,000$136,474,800dollars as filed
NUVALENT INC COM670703107Stock1,487,756$111,715,598dollars as filed
XENON PHARMACEUTICALS INC COM98420N105Stock2,167,793$93,323,489dollars as filed
SPYRE THERAPEUTICS INC00773J202COM NEW1,884,084$71,463,306dollars as filed
ENLIVEN THERAPEUTICS INC COM29337E102Stock3,973,245$69,889,380dollars as filed
VAXCYTE INC COM92243G108Stock860,000$58,746,600dollars as filed
MIND MEDICINE MINDMED INC60255C885COM NEW5,833,333$54,833,330dollars as filed
ALPINE IMMUNE SCIENCES INC02083G100COM1,375,000$54,505,000dollars as filed
ARVINAS INC04335A105COM1,275,000$52,632,000dollars as filed
RHYTHM PHARMACEUTICALS INC76243J105COM1,050,000$45,496,500dollars as filed
COGENT BIOSCIENCES INC19240Q201COM6,425,000$43,176,000dollars as filed
PHARVARIS NVN69605108COMMON STOCK1,725,000$39,864,750dollars as filed
CELLDEX THERAPEUTICS INC NEW15117B202COM NEW866,468$36,365,662dollars as filed
NKARTA INC65487U108COMMON STOCK3,165,000$34,213,650dollars as filed
VIRIDIAN THERAPEUTICS INC92790C104COM1,934,653$33,875,774dollars as filed
CELCUITY INC15102K100COM1,555,954$33,608,606dollars as filed
KURA ONCOLOGY INC COM50127T109Stock1,525,000$32,528,250dollars as filed
C4 THERAPEUTICS INC12529R107COM STK3,410,384$27,862,837dollars as filed
ORIC PHARMACEUTICALS INC68622P109COM2,000,000$27,500,000dollars as filed
ABIVAX SA-00370M103SPONSORED ADS1,895,003$27,098,543dollars as filed
PERSPECTIVE THERAPEUTICS INC46489V104COM21,052,631$25,052,631dollars as filed
IMMUNOVANT INC45258J102COM750,990$24,264,487dollars as filed
KYVERNA THERAPEUTICS INC501976104COMMON STOCK912,189$22,658,775dollars as filed
ENGENE HOLDINGS INC29286M105COM1,250,000$21,187,500dollars as filed
APOGEE THERAPEUTICS INC COM03770N101Stock290,000$19,270,500dollars as filed
CABALETTA BIO INC12674W109COMMON STOCK1,100,000$18,766,000dollars as filed
AUTOLUS THERAPEUTICS PLC SPON05280R100COM2,300,000$14,674,000dollars as filed
THIRD HARMONIC BIO INC88427A107COM1,250,000$11,800,000dollars as filed
NEUROGENE INC64135M105COMMON STOCK200,000$10,180,000dollars as filed
ADVERUM BIOTECHNOLOGIES INC00773U207COM NEW657,333$9,294,689dollars as filed
VISTAGEN THERAPEUTICS INC92840H400COM1,575,000$8,316,000dollars as filed
SYNDAX PHARMACEUTICALS INC87164F105COM318,851$7,588,654dollars as filed
SOLENO THERAPEUTICS INC834203309COM169,533$7,256,012dollars as filed
HELIX ACQUISITION CORP IIG4444H101CL A ORD SHS500,000$5,200,000dollars as filed
MACROGENICS INC556099109COM295,020$4,342,694dollars as filed
ADICET BIO INC007002108COM1,374,320$3,229,652dollars as filed
SAB BIOTHERAPEUTICS INC78397T202COMMON STOCK183,174$831,610dollars as filed
DBV TECHNOLOGIES S A23306J101ADR92,687$69,432dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001831942-24-000006this filing2024-05-15acceptance time not in the bulk data set